Skip to main content

In the spotlight
North Texas Angel Network Invests in Corganics, Paving the Way for Cannabinoid Therapy Innovation

(DALLAS, TX - November, 15  2024) - The North Texas Angel Network  (NTAN) just invested $125,000 in Corganics, a company with a mission to make cannabinoid therapy easier to access across the U.S. This investment is a big deal for Corganic; they'll be able to keep growing, hire new team members, and get closer to becoming a go to source for safe and effective cannabinoid products.

“NTAN members were really inspired by Corganic goals,” said Tim Shroyer, an NTAN member. “We’re excited to see them keep growing as they work toward becoming the go-to source for cannabinoid therapy in the U.S.”

NTAN is all about supporting early stage companies like Corganics, and their members bring experience from a plethora of industries. By investing in Corganics, NTAN isn’t just offering funding but also guidance from people who know how to build businesses. It’s a prime example of NTAN’s commitment to helping new companies that have a positive mission.

“Working with NTAN has been amazing,” said Chad Collins, Co-Founder of Corganics. “From our first presentation to closing the deal, they’ve been so professional and supportive. Their investment has already helped us bring on new talent and build momentum.”

Corganics is super focused on quality, using organic ingredients and eco-friendly packaging for their products, which aim to support wellness and responsible cannabis use. They’re especially interested in providing alternatives to opioids, which is why their products are often marketed through doctors and hospitals. This approach not only aids their credibility but also helps Corganics build a community around responsible cannabinoid therapy.

“NTAN members were really inspired by Corganics goals,” said Tim Shroyer, an NTAN member. “We’re excited to see them keep growing as they work toward becoming the go-to source for cannabinoid therapy in the U.S.”

Jeff Murphy, Executive Director of NTAN, adds, “NTAN investors have seen the dynamic  growth of the CBD business and chose to invest in Corganics. Corganics primary avenue to market is via doctor groups and hospitals looking for alternatives to opioids for pain, our investors see this GTM strategy as a real win for Corganics as it gives credibility for the product offering.  <a href="https://www.northtexasangels.org/"> About North Texas Angel Network

About NTAN

Since 2008, the North Texas Angel Network (NTAN) has connected early-stage companies with angel investors to help private investors make private deals with private companies. The nonprofit, member-led organization reviews investment opportunities across industries, including medical device and service companies, AI, Fintech,  software and hardware technology, among others. One of the oldest and largest networks in Texas, NTAN is a member of the Angel Capital Association. Follow NTAN on LinkedIn to learn more.

About Corganics

Corganics, based in Dallas, is a medically focused life sciences company created by senior pharmaceutical industry leaders and physician advisors. We are dedicated to the research, development and commercialization of medical grade cannabinoid (CBD) therapeutic products utilizing cutting edge absorption technology in our delivery. Corganics products are superior in quality to retail CBD while being cleaner, safer, more transparent, THC-free and are the most trusted and recommended CBD therapy in the U.S.and exclusively available through healthcare professionals.

Get in touch
We're here to assist you!